Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

LatchBio

Request full access

AI agents and data infrastructure for biology research

San Francisco, United StatesFounded 2021Biotech & Life Sciences

About LatchBio

LatchBio is a San Francisco-based company that builds software infrastructure for biological research, with a current focus on researching, evaluating and improving AI agents for biology. The company was founded in 2021 by Alfredo Andere, Kenny Workman and Kyle Giffin, who met as undergraduates at the University of California, Berkeley. Its stated mission is to build and disseminate the data infrastructure for what it calls the biocomputing revolution.

The company began with a web-based platform that lets biologists store, process and visualize experimental data without writing code or setting up cloud infrastructure. Researchers can import files from their existing data stacks, run popular bioinformatics pipelines and visualization tools such as RNA-seq, CRISPR analysis and protein structure prediction, and work with results through a browser. Bioinformaticians can publish workflows through the LatchBio SDK, which automatically generates no-code interfaces for wet-lab scientists, while serverless infrastructure handles storage and compute at scale.

LatchBio has since extended its work into agentic AI for the life sciences. It publishes a series of verifiable benchmarks that test how well AI agents analyze real biological data, covering areas such as single-cell and spatial biology, epigenomics, metagenomics, genetic variant interpretation, oncology, neuroscience, rare disease diagnosis and therapeutic discovery for antibodies, oligonucleotides and small molecules. A dedicated biosecurity programme evaluates agent capabilities and refusals in pathogen surveillance, structural risk assessment and countermeasure design.

The company serves pharmaceutical, biotechnology and academic research teams and sells its software on a subscription basis. It is hiring scientists, engineers and operators in San Francisco and remotely.

Source: Dealroom company data

At a glance

Status
Operational
Employees
41
Open positions
9
Dealroom signal
95.1/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Drug Development, Synthetic Biology, Sustainable Development Goals, Tech for Biotech and Pharma, Biotech and Pharma, Climate Tech, Techbio, Techbio Drug Discovery, Digital Pharma
Business model
SaaS
Client focus
B2B

Open roles

43 open roles
RoleTeamLocationPosted
Member of Technical Staff, Medicinal ChemistrySan Francisco, US2d ago
Member of Technical Staff, Molecular DesignDesignDesignSan Francisco, US2d ago
Member of Technical Staff, Experimental Biology & Assay DevelopmentSan Francisco, US2d ago
Member of Technical Staff, ChemistrySan Francisco, US2d ago
Member of Technical Staff, Translational ScienceSan Francisco, US2d ago
Member of Technical Staff, Clinical DevelopmentClinicalClinicalSan Francisco, US2d ago
Member of Technical Staff, Clinical OperationsClinicalClinicalSan Francisco, US2d ago
Member of Technical Staff, Clinical Data & Statistical ProgrammingClinicalClinicalSan Francisco, US2d ago
Member of Technical Staff, Biostatistics & Trial DesignDesignDesignSan Francisco, US2d ago
AI Biologist - Gene Therapy DiscoverySan Francisco (preferred) · Remote3d ago
AI Biologist - Cell Therapy DiscoverySan Francisco (preferred) · Remote3d ago
AI Biologist - MetabolomicsSan Francisco (preferred) · Remote3d ago
From the company's careers page. The newest 12 of 43. Careers page ↗More startups hiring →

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Apr 2026 $130M $500M Undisclosed ↗
SERIES AOther financing Jun 2022 $28M $112M Haystack · Caffeinated Capital · Lux Capital · Hummingbird Ventures ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

LatchBio website traffic

Latest recorded traffic for LatchBio is 29K monthly website visits, up 81.3% over the last three months. LatchBio's team grew 173.3% over the past year.

Latest monthly visits29K 3-month web change+81.3% 1-year team growth+173.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

LatchBio in the San Francisco ecosystem

Live from Dealroom

The LatchBio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed6 investors entered at this stage

Series A3 investors entered at this stage

Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Francisco HQ
Book a demo for the full country breakdown

See LatchBio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.